19 signals · bluesky, h1b_lca, News / RSS +1 more
Scores are directional signals derived from aggregated public data — not verified findings or investment advice. Methodology
Signal-based estimates from public data — not verified assessments. Learn more
Some stress signals present but below significant thresholds.
Low-to-moderate risk signals with no major red flags in current data.
Bristol-Myers Squibb signals mixed analyst sentiment and workforce adjustments amid moderate stress and low risk levels, with limited but conflicting signals on hiring and layoffs.
Patterns indicate a cautious outlook for Bristol-Myers Squibb, with analyst downgrades and price target reductions suggesting potential near-term headwinds, while layoff data and hiring signals (e.g., H-1B filings) reflect ongoing workforce restructuring. However, the overall stress and risk levels remain relatively low, and confidence in these signals is moderate (65.9/100), warranting cautious interpretation given the limited review sample size.
Leerink Partners Downgrades Bristol-Myers Squibb to Market Perform From Outperform, Cuts Price Target to $59 From $73 marketscreener.com
#AnalystRatings Leerink Partners downgraded Bristol-Myers Squibb from Outperform to Market Perform on October 5, cutting its price target to $59 from $73. Analyst David Risinger cited growing skepticism about key late-stage pipeline candidates set to report clinical data in the ... Continue reading
#AnalystRatings Leerink Partners downgraded Bristol-Myers Squibb from Outperform to Market Perform on October 5, cutting its price target to $59 from $73.
Global biopharmaceutical company.
Based on 19 signals across 4 sources · snapshot 6 Oct 2026
Strong: enough recent evidence to trust this score.
Overall community sentiment for Bristol-Myers Squibb is positive based on public signals as of 6 Oct 2026.
Based on 19 signals across 4 sources
Scores are directional signals derived from public data — not certified assessments or recommendations. Confidence indicates data coverage, not accuracy. Learn how scores are calculated →
Derived from public sources such as news, filings, and reported events.
What this means
Signals suggest a mixed picture — review the evidence below for context.
AI-generated from public signals — may be incomplete. Based on 4 recent signals.
This summary is generated from publicly available review and signal data. It is intended as an indicative overview only and should not be used as the sole basis for employment, investment, or business decisions. Signal volume and source diversity may limit representativeness.
AI summaries are generated from public signals and may not reflect the full picture.
How many is "large -scale"? Bristol-Myers Squibb had 1,262 layoffs in 2024, 1,156 layoffs announced in 2025, and has fired at least 453 employees locally from its Lawrence NJ site so far this year. They do employ around 30,000 people worldwide though, so that is only ~10% of their workforce.
Bristol-Myers Squibb had 1,262 layoffs in 2024, 1,156 layoffs announced in 2025, and has fired at least 453 employees locally from its Lawrence NJ site so far this year.